Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Anavex
Biotech
Biopharma veteran takes her CEO Cue—Chutes & Ladders
Biopharma veteran takes her CEO Cue. Kyverna nabs commercial chief to prep for launch. Anavex promotes from within after ousting CEO.
Darren Incorvaia
,
Zoey Becker
,
Will Maddox
May 8, 2026 8:30am
Anavex stock sinks 30% as lead asset fails in Rett syndrome
Jan 2, 2024 12:08pm
Fierce Biotech's Rotten Tomatoes of 2022
Dec 19, 2022 3:00am
After changing study goals, Anavex touts Rett syndrome win
Feb 1, 2022 11:26am
Annovis' Alzheimer's drug fails to improve dementia symptoms
Jul 28, 2021 8:00pm
Ipsen pays $28M upfront for IRLAB's Phase 2b Parkinson's drug
Jul 15, 2021 2:05pm